Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

A pathologic study of explanted parachute devices from seven heart failure patients following percutaneous ventricular restoration.

Ladich E, Otsuka F, Virmani R.

Catheter Cardiovasc Interv. 2014 Mar 1;83(4):619-30.

PMID:
23703961
2.

Percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure: three-year outcomes of the PARACHUTE first-in-human study.

Costa MA, Mazzaferri EL Jr, Sievert H, Abraham WT.

Circ Heart Fail. 2014 Sep;7(5):752-8. doi: 10.1161/CIRCHEARTFAILURE.114.001127. Epub 2014 Jul 18.

3.

Left Ventricular Assist Device Implantation After Intracardiac Parachute Device Removal.

Abu Saleh WK, Al Jabbari O, Bruckner BA, Suarez EE, Estep JD, Loebe M.

Ann Thorac Surg. 2015 Aug;100(2):720-2. doi: 10.1016/j.athoracsur.2014.10.017.

PMID:
26234850
4.

The PARACHUTE IV trial design and rationale: percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure and dilated left ventricles.

Costa MA, Pencina M, Nikolic S, Engels T, Templin B, Abraham WT.

Am Heart J. 2013 Apr;165(4):531-6. doi: 10.1016/j.ahj.2012.12.022. Epub 2013 Feb 19.

PMID:
23537969
6.

Impact of pump replacement on outcome in advanced heart failure patients with left ventricular assist system.

Iwashima Y, Yanase M, Horio T, Seguchi O, Murata Y, Fujita T, Toda K, Kawano Y, Nakatani T.

Artif Organs. 2013 Jul;37(7):606-14. doi: 10.1111/aor.12045. Epub 2013 May 20.

PMID:
23692322
7.

Evaluating the quality of implantation of percutaneous ventricular restoration device (Parachute®) by cardiac computed tomography.

Alaiti MA, Fares A, Erglis A, Nshisso L, Shaikh K, DeCicco AE, Nasif M, Alkhalil A, Ince H, Abraham WT, Simon DI, Costa MA, Attizzani GF, Bezerra HG.

Catheter Cardiovasc Interv. 2017 Mar 1;89(4):E104-E111. doi: 10.1002/ccd.26644. Epub 2016 Jul 29.

PMID:
27470983
8.

Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):174-81. doi: 10.1016/j.jtcvs.2010.03.037. Epub 2010 May 5.

9.

Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement.

Soderlund KA, Chivukula RR, Russell SD, Conte JV, Mudd JO, Halushka MK.

Cardiovasc Pathol. 2009 Jul-Aug;18(4):217-22. doi: 10.1016/j.carpath.2008.06.007. Epub 2008 Aug 15.

PMID:
18706833
10.

Partial aortic valve fusion induced by left ventricular assist device.

Rose AG, Park SJ, Bank AJ, Miller LW.

Ann Thorac Surg. 2000 Oct;70(4):1270-4.

PMID:
11081884
11.

Ventricular assist device support in children and adolescents with heart failure: the Children's Medical Center of Dallas experience.

Sharma MS, Forbess JM, Guleserian KJ.

Artif Organs. 2012 Jul;36(7):635-9. doi: 10.1111/j.1525-1594.2012.01443.x. Epub 2012 Apr 12.

PMID:
22497304
12.

Granulomatous myocarditis in severe heart failure patients undergoing implantation of a left ventricular assist device.

Segura AM, Radovancevic R, Demirozu ZT, Frazier OH, Buja LM.

Cardiovasc Pathol. 2014 Jan-Feb;23(1):17-20. doi: 10.1016/j.carpath.2013.06.005. Epub 2013 Aug 6. Review.

PMID:
23928368
13.

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.

Kamdar F, John R, Eckman P, Colvin-Adams M, Shumway SJ, Liao K.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):575-81. doi: 10.1016/j.jtcvs.2012.09.095.

14.

De novo development of eosinophilic myocarditis with left ventricular assist device support as bridge to transplant.

Pereira NL, Park SJ, Daly RC, Kushwaha SS, Edwards WD.

Ann Thorac Surg. 2010 Oct;90(4):1345-7. doi: 10.1016/j.athoracsur.2010.03.029.

PMID:
20868843
15.

Use of left ventricular assist device (HeartMate II): a Singapore experience.

Lim CP, Sivathasan C, Tan TE, Lim CH, Kerk KL, Sim DK.

Artif Organs. 2014 Jul;38(7):543-8. doi: 10.1111/aor.12247. Epub 2014 Jan 7.

PMID:
24392937
16.

Low bearing wear in explanted HeartMate II left ventricular assist devices after chronic clinical support.

Sundareswaran KS, Reichenbach SH, Masterson KB, Butler KC, Farrar DJ.

ASAIO J. 2013 Jan-Feb;59(1):41-5. doi: 10.1097/MAT.0b013e3182768cfb.

PMID:
23263335
17.

New circulatory support system: heartware.

Ozbaran M, Yagdi T, Engin C, Nalbantgil S, Ayik F, Oguz E, Engin Y, ├ľzturk P.

Transplant Proc. 2012 Jul-Aug;44(6):1726-8. doi: 10.1016/j.transproceed.2012.05.043.

PMID:
22841255
18.

Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon.

Uriel N, Han J, Morrison KA, Nahumi N, Yuzefpolskaya M, Garan AR, Duong J, Colombo PC, Takayama H, Thomas S, Naka Y, Jorde UP.

J Heart Lung Transplant. 2014 Jan;33(1):51-9. doi: 10.1016/j.healun.2013.10.005. Epub 2013 Nov 28.

PMID:
24290832
19.

Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?

Sabashnikov A, Popov AF, Bowles CT, Mohite PN, Weymann A, Hards R, Hedger M, Wittwer T, Wippermann J, Wahlers T, Schoendube FA, Simon AR.

J Thorac Cardiovasc Surg. 2014 Sep;148(3):1115-21; discussion 1021-2. doi: 10.1016/j.jtcvs.2014.05.063. Epub 2014 Jun 6.

20.

Intracardiac giant cells after left ventricular assist device placement.

Fenton H, Judge DP, Yuh DD, Halushka MK.

J Heart Lung Transplant. 2007 Apr;26(4):417-20.

PMID:
17403488

Supplemental Content

Support Center